Alphatec Holdings, Inc. (FRA:L1Z1)

Market Cap	1.53B -23.3%
Revenue (ttm)	713.42M +19.5%
Net Income	-96.28M
EPS	-0.64
Shares Out	n/a
PE Ratio	n/a
Forward PE	22.48
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10
Open	9.80
Previous Close	9.30
Day's Range	9.80 - 9.80
52-Week Range	5.65 - 19.28
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Alphatec Holdings

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-o...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1990
• Employees: 913
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: L1Z1

Financial Performance

In 2025, Alphatec Holdings's revenue was $764.16 million, an increase of 24.95% compared to the previous year's $611.56 million. Losses were -$143.36 million, -11.57% less than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error